ArticleOncology letters2019

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials.

Hiromichi Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.